| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 954 | 4.112 | 2.228 | 1.752 | 5.278 | 4.294 | 1.801 | 4.943 | 3.614 | 5.224 |
| Total Income - EUR | 954 | 4.112 | 2.228 | 1.752 | 5.278 | 4.295 | 1.810 | 5.136 | 3.618 | 5.225 |
| Total Expenses - EUR | 367 | 795 | 55 | 588 | 907 | 846 | 1.484 | 334 | 1.959 | 1.380 |
| Gross Profit/Loss - EUR | 587 | 3.316 | 2.174 | 1.164 | 4.371 | 3.449 | 326 | 4.802 | 1.659 | 3.845 |
| Net Profit/Loss - EUR | 558 | 3.193 | 2.113 | 1.133 | 4.212 | 3.320 | 272 | 4.654 | 1.223 | 3.056 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Crismed - Sgc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.629 | 15.817 | 17.671 | 7.170 | 11.061 | 14.187 | 14.145 | 14.935 | 11.668 | 13.945 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 844 | 710 | 762 | 206 | 3.322 | 2.910 | 784 | 3.461 | 7.537 | 5.910 |
| Cash | 11.786 | 15.107 | 16.910 | 6.964 | 7.738 | 11.277 | 13.361 | 11.474 | 4.132 | 8.034 |
| Shareholders Funds | 12.569 | 15.633 | 17.482 | 6.984 | 11.061 | 14.171 | 14.129 | 10.289 | 11.480 | 13.467 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 61 | 183 | 189 | 186 | 0 | 17 | 16 | 4.647 | 188 | 477 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crismed - Sgc Srl